Commercialisation, partnerships and industry
"We have a great story to tell industry: a growing pipeline of discoveries, and the right people and platforms for collaboration."
At the Monash Biomedicine Discovery Institute, we’re working with leading pharmaceutical and biotechnology companies to develop our discoveries, with more than 20 potential therapies in the pipeline.
We want our research to deliver even greater benefits to society and solve unmet medical needs. To that end, we have already partnered some of our most promising research with leading biotechnology companies such as Novo Nordisk, Eli Lily, Ono Pharmaceutics, CSL, Roche, and GSK. Monash’s state-of-the-art integrated platform technologies work with local small and medium enterprises, such as Trajan and MiniFab and international corporations like CSL, Tecan, MedImmune and others.
Monash is a big organisation, it can be confusing to know where to go in the initial stages, so we suggest you initially reach out to Michael, or to the FMNHS BD team, we will work with you and guide you from there. We encourage you to get in touch with us to find out how we can work together.
We encourage you to get in touch with us to find out how we can work together.